Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027307
Filing Date
2022-11-14
Accepted
2022-11-14 16:30:35
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20220930_10q.htm   iXBRL 10-Q 1924962
2 EXHIBIT 31.1 ex_444119.htm EX-31.1 8078
3 EXHIBIT 31.2 ex_444120.htm EX-31.2 8055
4 EXHIBIT 32.1 ex_444121.htm EX-32.1 6361
  Complete submission text file 0001437749-22-027307.txt   8351356

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acrx-20220930.xsd EX-101.SCH 73391
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20220930_cal.xml EX-101.CAL 50621
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20220930_def.xml EX-101.DEF 491440
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20220930_lab.xml EX-101.LAB 431213
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20220930_pre.xml EX-101.PRE 525495
75 EXTRACTED XBRL INSTANCE DOCUMENT acrx20220930_10q_htm.xml XML 1389785
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 221386353
SIC: 2834 Pharmaceutical Preparations